Contact
Please use this form to send email to PR contact of this press release:
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal
TO:
Please use this form to send email to PR contact of this press release:
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal
TO: